The Clinical, Regulatory and Commercial Implications of Rapid Approval
July 12, 2016
July 12, 2016 | London, UK | St. Pancras Renaissance Hotel
Join us for a day of invitation-only executive roundtables exploring accelerated pathways, their challenges, and the development innovation they have ignited.
Rapid approval has presented noted opportunity in the U.S. and Europe (with Japan on the forefront). Yet the varied nature and diversity of payer and regulatory landscapes in these regions are generating new and unanticipated challenges. Biopharmaceutical companies small to large are responding, with development innovations worthy of discussion.
Perspectives and Insights
- Accelerated Clinical Development: The Payer Challenge
- The Faces & Facets of Innovation: Clinical, Regulatory, Commercial
- Demonstrating Value & Managing Risk: Getting it Right
- Early is Working: Regulatory, HTA Agencies & EUnetHTA
Who is Attending
C-suites, Heads of R&D, Clinical Development, Medical Affairs, Regulatory Affairs, and Commercialization (Market Access, Reimbursement, HEOR)
St. Pancras Renaissance London Hotel
London NW1 2AR